rss
Br J Ophthalmol 2004;88:344-347 doi:10.1136/bjo.2003.027177
  • Clinical science
    • Scientific reports

Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degeneration

  1. E Rechtman1,2,
  2. R P Danis1,3,
  3. L M Pratt1,
  4. A Harris1
  1. 1Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, IN, USA
  2. 2Department of Ophthalmology, Kaplan Medical Center, Rehovot, Israel
  3. 3Department of Ophthalmology and Visual Sciences, University of Wisconsin Medical School, Madison, WI, USA
  1. Correspondence to: Dr R P Danis Department of Ophthalmology and Visual Sciences, University of Wisconsin Medical School, Park West One, 406 Science Drive, Suite 400, Madison, WI, 53711-1068, USA; rdanisrc.ophth.wisc.edu; ehudrechtmanyahoo.com
  • Accepted 18 August 2003

Abstract

Aims: To report the effects of intravitreal triamcinolone acetonide (iTAAC) injections as an adjunctive treatment to photodynamic therapy (PDT) with verteporfin for new subfoveal choroidal neovascularisation (CNV) in age related macular degeneration (AMD).

Methods: We retrospectively reviewed the records of all AMD patients who had iTAAC within 6 weeks of their first PDT and had a follow up of one year or longer. The proportion of eyes after one year follow up that lost or gained ≥15 and ≥30 ETDRS letters, baseline and one year lesion greatest linear dimension (GLD), number of PDTs, and side effects were assessed.

Results: Fourteen patients were evaluated. Eleven received one initial combined treatment and three received an additional combined treatment after 6 months. Median follow up was 18 months (range 12 to 25 months). Overall, 7% gained ≥30 letters, 50% maintained stable vision, 14% lost 15–29 letters, and 29% lost ≥30 letters. Overall, mean GLD increased from 2580 (SD 1088) µm to 3946 (SD 1503) µm (p = 0.01). The mean number of PDTs during the first year was 2.57. Side effects were mild intraocular pressure elevation in 28.5% and cataract progression in 50% of phakic eyes.

Conclusions: iTAAC with PDT in AMD was found to be relatively safe and had reasonable results for lesions with some classic component.

Footnotes

    This Article

    1. Abstract
    2. Full text
    3. PDF

    Services

    1. Email this link to a friend
    2. Alert me when this article is cited
    3. Alert me if a correction is posted
    4. Alert me when eletters are published
    5. Article Usage Statistics
    6. Similar articles in this journal
    7. Similar articles in Web of Science
    8. Similar articles in PubMed
    9. Add article to my folders
    10. Download to citation manager
    11. Request permissions

    Responses

    1. Submit a response
    2. No responses published

    Social bookmarking

    Register for free content


    Free sample
     This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
    View free sample issue >>

    Free archive
    The full back archive is now available for BJO. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
    Register to access the free archive >>

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.